7. October 2009 08:37
The team headed by Doctor Manuel Casal, head of Microbiology at Reina Sofia Hospital in Cordoba has validated in patients a technique, originally produced by a German company, capable of diagnosing tuberculosis in only one day and determining whether or not it is resistant to two of the drugs used to treat this disease.
[More]
28. September 2009 06:28
Merck has thoroughly reviewed the safety data for sitagliptin, and sitagliptin was not associated with an increase in the incidence of pancreatitis in preclinical studies or in clinical trials of up to two years in duration with more than 6,000 patients.
[More]
d74596e6-7627-487a-8948-6d3a262aac44|0|.0
Posted in: Pharmaceutical News
Tags: Abdominal Pain, Amiloride, Anemia, Angioedema, Blindness, Breast Milk, Calcium, Cell, Chloramphenicol, Chromosome, Congestive Heart Failure, Creatinine, Cyclosporine, Dehydration, Diabetes, Diabetes Mellitus, Diabetic Ketoacidosis, Dialysis, Diarrhea, Diet, DNA, Estradiol, Ethanol, Exercise, Fertility, Furosemide, Glibenclamide, Headache, Heart Failure, Hospital, Hyperglycemia, Hyperinsulinemia, Hypersensitivity, Hypoglycemia, Hypothermia, Ibuprofen, Indigestion, Insulin, Isoniazid, Kidney Disease, Lymphoma, Metabolism, Metformin, Morphine, Nausea, Nursing, Obesity, Pancreatitis, Pharmacology, Pioglitazone, Pregnancy, Quinine, Salicylates, Sepsis, Septicemia, Sore Throat, Stress, Stroke, Sulfonylurea, Thiazolidinediones, Toxicology, Trauma, Type 1 Diabetes, Type 2 Diabetes, Urticaria, Vasculitis, Vomiting, Warfarin
26. September 2009 01:23
Merck & Co., Inc., which operates in many countries as Merck Sharp & Dohme (MSD), has received a positive opinion from the European Medicines Agency’s (EMEA) Committee for Medicinal Products for Human Use (CHMP) for JANUVIA® tablets and JANUMET® tablets recommending their use as add-on to insulin for the treatment of type 2 diabetes.
[More]
1bb97984-dc46-45df-bc40-6f1f87e81cff|1|5.0
Posted in: Medical Condition News | Pharmaceutical News
Tags: Abdominal Pain, Amiloride, Anemia, Angioedema, Blindness, Breast Milk, Calcium, Cell, Chloramphenicol, Chromosome, Congestive Heart Failure, Creatinine, Cyclosporine, Dehydration, Diabetes, Diabetes Mellitus, Diabetic Ketoacidosis, Dialysis, Diarrhea, Diet, DNA, Estradiol, Ethanol, Exercise, Fertility, Furosemide, Glibenclamide, Headache, Heart Failure, Hospital, Hyperglycemia, Hyperinsulinemia, Hypersensitivity, Hypoglycemia, Hypothermia, Ibuprofen, Indigestion, Insulin, Insulin Resistance, Isoniazid, Kidney Disease, Lymphoma, Metabolism, Metformin, Morphine, Nausea, New Drug Application, Nursing, Obesity, Pancreatitis, Pharmacology, Pioglitazone, Pregnancy, Quinine, Salicylates, Sepsis, Septicemia, Sore Throat, Stress, Stroke, Sulfonylurea, Thiazolidinediones, Toxicology, Trauma, Type 1 Diabetes, Type 2 Diabetes, Urticaria, Vasculitis, Vomiting, Warfarin
24. June 2009 23:59
The journal Lancet Infectious Diseases examines the worldwide spread of extensively drug-resistant tuberculosis (XDR-TB). Currently, about 500,000 of the 9 million new cases of TB that are identified each year are strains of XDR-TB. "Drug resistance is largely man-made - it is vitally important to review antibiotic treatment strategies and to ensure the Stop TB Strategy is fully applied to prevent further selection of drug-resistant mutants," Leonard Amaral of Universidade Nova de Lisboa said.
[More]
30. March 2009 12:52
The discovery of a large number of slow-growing Mycobacterium tuberculosis bacteria, which cause tuberculosis (TB), in the lungs of TB patients could be an important step forward in the design of new anti-TB drugs.
[More]
24. March 2009 18:51
Researchers at McGill University in Montreal on Tuesday announced they will soon launch an international clinical trial to determine if latent tuberculosis can be treated successfully with a four-month treatment course of the TB drug rifampin rather than the standard nine-month treatment with the TB drug isoniazid, the CP/Toronto Sun reports.
[More]
2. March 2009 16:59
New guidelines proposed in the March 2009 issue of the journal Pediatrics by researchers from the Indiana University School of Medicine and Riley Hospital for Children may have a major impact on how pediatricians and family physicians treat non-active tuberculosis (TB) in children who are immigrants, internationally adopted or refugees.
[More]
26. February 2009 21:44
A combination of two FDA-approved drugs, already approved for fighting other bacterial infections, shows potential for treating extensively drug resistant tuberculosis (XDR-TB), the most deadly form of the infection.
[More]
95da3ba7-5fb0-4128-8c6b-7fc96806f7ae|0|.0
Posted in: Disease/Infection News
Tags: Allergy, Amoxicillin, Antibiotic, Biochemistry, Brain, Cancer, Cardiology, Cough, Diabetes, Education, Health Disparities, HIV/AIDS, Hospital, Immunology, Isoniazid, Neurology, Neuroscience, Neurosurgery, Obesity, Pandemic, Pediatrics, Penicillin, Potassium, Psychiatry, Seniors, Sleep, Sleep Disorder, Tuberculosis, XDR-Tuberculosis
23. January 2009 03:37
Patients who are infected with the latent form of tuberculosis (TB) show no symptoms and are not contagious, yet they pose the biggest challenge when it comes to controlling the disease.
[More]
11. November 2008 23:06
A new report suggests that the number of cases of extensively drug-resistant tuberculosis (XDR-TB) in the U.S. has declined in the past fifteen years, but new cases continue to be reported, according to the study published in the November 12 issue of JAMA.
[More]
42bf682a-5bd2-43bf-b022-8d6549006f62|0|.0
Posted in: Disease/Infection News
Tags: Amikacin, Capreomycin, Drug-Resistant Tuberculosis, Fluoroquinolone, Hispanic Health, HIV/AIDS, Isoniazid, Kanamycin, Tuberculosis, Virus, XDR-Tuberculosis
13. August 2008 21:00
In the first statewide study of extensively drug-resistant tuberculosis (XDR TB) in the United States, California officials have identified 18 cases of the dangerous and difficult-to-treat disease between 1993 and 2006, and 77 cases that were one step away from XDR TB. The study appears in the August 15 issue of Clinical Infectious Diseases, now available online.
[More]
13. August 2008 20:07
Only 1% of people living with HIV/AIDS worldwide have been screened for tuberculosis, according to a report recently released by the coalition Advocacy To Control TB Internationally, or ACTION, Reuters reports.
[More]
4. August 2008 15:49
Health and criminal justice authorities need to provide targeted services to drug users, especially those who inject drugs, to prevent and treat tuberculosis (TB) and HIV. TB is a major cause of death for people living with HIV, but drug users who are HIV-positive face stigma, discrimination and barriers to accessing life-saving treatments.
[More]
22. July 2008 20:20
In resource-limited settings where tuberculosis is a major cause of mortality among HIV patients and where a multidrug-resistant TB epidemic is emerging, researchers are pressing for approaches to integrate TB prevention and treatment into HIV care and treatment.
[More]
1. July 2008 04:45
Researchers have developed a new test which can quickly detect multi drug-resistant tuberculosis (MDR-TB).
[More] 
Subscribe